Advertisement
U.S. markets closed

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.4800-0.0100 (-0.67%)
At close: 04:00PM EDT
1.4711 -0.01 (-0.60%)
After hours: 07:01PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close1.4900
Open1.4700
Bid1.4600 x 600
Ask1.4900 x 100
Day's Range1.4600 - 1.5050
52 Week Range0.7100 - 1.9600
Volume782,296
Avg. Volume1,106,918
Market Cap263.091M
Beta (5Y Monthly)0.96
PE Ratio (TTM)N/A
EPS (TTM)-0.1400
Earnings DateApr 30, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.46
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RIGL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rigel Pharmaceuticals, Inc.
    Technical Assessment: Neutral in the Intermediate-TermWas that a case of quarter-end buying by institutions? Over the last 50 minutes of the trading session on Wednesday, the S&P 500 (SPX) took off like a rocket, surging 30 points and finishing 0.9% higher on the day and at another all-time high. But the biggest winners on the day were small-caps, with the Russell 2000 (IWM) surging 2.2% and the S&P 600 (SML) spiking 2.4%. The IWM is breaking out of a more-than two-year base and closed at its highest level since December 2021.
    Rating
    Fair Value
    Economic Moat
    14 hours agoArgus Research
View more